Full Year 2023 GAAP Revenue of $882 million
Full Year 2023 GAAP Net Income of $73 million
Full Year 2023 GAAP Diluted Earnings Per Share of $2.02
Full Year 2023 Adjusted Earnings Per Share.
Taylor Morrison Reports Fourth Quarter and Full Year 2023 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Fourth Quarter 2023 Highlights Versus Prior Year
Net Sales of $1,621 million, up 16% as reported, or 14% in constant currency
Gross Margin of 48.8%, an increase of 580 basis points; Adjusted.
Surpasses $100 Billion in Total AUM
520bps of Operating Margin Expansion vs. the Prior Year
Diluted Earnings Per Share of $0.16
13% Annualized Organic Growth Rate Across All Products
.
Fourth-Quarter and Full-Year Sales Reflect Sustained Growth Across Oncology and Vaccines
Fourth-Quarter Worldwide Sales Were $14.6 Billion, an Increase of 6% From Fourth Quarter 2022; Excluding.